HSBC Holdings
SGMO

HSBC Holdings’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

HSBC Holdings’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,559
Closed -$7.46K – 3135
2024
Q2 		$7.46K Sell
19,559
-561
-3% -$303 ﹤0.01% 2902
2024
Q1 		$13.5K Sell
20,120
-36,844
-65% -$26.7K ﹤0.01% 3011
2023
Q4 		$32.6K Buy
56,964
+420
+0.7% +$194 ﹤0.01% 2671
2023
Q3 		$33.9K Hold
56,544
– – ﹤0.01% 2658
2023
Q2 		$73.2K Hold
56,544
– – ﹤0.01% 2471
2023
Q1 		$98.1K Buy
56,544
+4,247
+8% +$12.1K ﹤0.01% 2511
2022
Q4 		$159K Hold
52,297
– – ﹤0.01% 2820
2022
Q3 		$262K Buy
52,297
+7,059
+16% +$36.3K ﹤0.01% 2488
2022
Q2 		$187K Buy
45,238
+29,324
+184% +$127K ﹤0.01% 2909
2022
Q1 		$94K Buy
+15,914
New +$94.6K ﹤0.01% 3133
2021
Q4 		– Sell
-22,158
Closed -$202K – 3342
2021
Q3 		$202K Buy
+22,158
New +$219K ﹤0.01% 2787
2021
Q1 		– Sell
-11,036
Closed -$174K – 3079
2020
Q4 		$174K Buy
+11,036
New +$129K ﹤0.01% 2850
2020
Q3 		– Sell
-44,086
Closed -$395K – 2844
2020
Q2 		$395K Buy
44,086
+12,048
+38% +$112K ﹤0.01% 1987
2020
Q1 		$199K Buy
+32,038
New +$238K ﹤0.01% 2302
2019
Q2 		– Sell
-30,500
Closed -$291K – 2837
2019
Q1 		$291K Sell
30,500
-35,008
-53% -$358K ﹤0.01% 2356
2018
Q4 		$752K Buy
+65,508
New +$814K ﹤0.01% 1934
2017
Q1 		– Sell
-11,961
Closed -$36K – 2525
2016
Q4 		$36K Buy
+11,961
New +$43.6K ﹤0.01% 2682

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

HSBC Holdings's SGMO Position: Q3 2024 in Review

HSBC Holdings sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2024, closing a stake of 19,559 shares — an estimated $7.46K sold.

HSBC Holdings first reported a position in SGMO in Q4 2016 and held it in 17 quarters. The position peaked at $752K in Q4 2018. 103 funds tracked by Wall St. Rank hold SGMO as of Q3 2024.

  • HSBC Holdings reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
  • HSBC Holdings sold 19,559 SANGAMO THERAPEUTICS INC shares in Q3 2024, an estimated $7.46K.
  • HSBC Holdings first reported a position in SANGAMO THERAPEUTICS INC in Q4 2016 and held it in 17 quarters.
  • HSBC Holdings's SANGAMO THERAPEUTICS INC position peaked at $752K in Q4 2018.
  • 103 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2024.

Based on HSBC Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.